Caffeine and the Kidney: What Evidence Right Now?

Journal of Renal Nutrition

Volumn 17, Issue 4, 2007, Pages 225-234

  Bolignano, Davide ^a   Coppolino, Giuseppe ^a   Barillà, Antonio ^a   Campo, Susanna ^a   Criseo, Manila ^a   Tripodo, Donatella ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; PHOSPHODIESTERASE INHIBITOR;

ARTICLE; DRUG EFFECT; EVIDENCE BASED MEDICINE; HUMAN; KIDNEY; PHYSIOLOGY; SAFETY;

CAFFEINE; CONSUMER PRODUCT SAFETY; EVIDENCE-BASED MEDICINE; HUMANS; KIDNEY; PHOSPHODIESTERASE INHIBITORS;

EID: 34250646545     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.02.006     Document Type: Article

References (70)

1. Barone J.J., and Roberts H.R. Caffeine consumption. Food Chem Toxicol 34 1 (1996) 119-129
2. Massey L.K. Caffeine and the elderly. Drugs Aging 13 1 (1998) 43-50
3. Butcher R.W., and Sutherland E.W. Adenosine 3′,5′-phosphate in biological materials. I. Purification and properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3′,5′-phosphate in human urine. J Biol Chem 237 (1962) 1244-1250
4. Snyder S.H., Katims J.J., Annau Z., Bruns R.F., and Daly J.W. Adenosine receptors and behavioral actions of methylxanthines. Proc Natl Acad Sci U S A 78 5 (1981) 3260-3264
5. Daly J.W., Butts-Lamb P., and Padgett W. Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines. Cell Mol Neurobiol 3 1 (1983) 69-80
6. Cuypers Y. Influence of caffeine and histamine on blood flow in artificially perfused kidneys. Arch Int Physiol Biochim 66 3 (1958) 457-459
7. Kincaid-Smith P., Saker B.M., and McKenzie I.F. Lesions in the vasa recta in experimental analgesic nephropathy. Lancet 1 7532 (1968) 24
8. Prescott L.F. Effects of acetylsalicylic acid, phenacetin, paracetamol and caffeine on renal tubular epithelium. Lancet 19 (1965) 91-95
9. Dorfman L.J., and Jarvik M.E. Comparative stimulant and diuretic actions of caffeine and theobromine in man. Clin Pharmacol Ther 11 6 (1970) 869-872
10. Massey L.K., and Wise K.J. The effect of dietary caffeine on urinary excretion of calcium, magnesium, sodium and potassium in healthy young females. Nutr Res 4 (1984) 43-50
11. Blanchard J., and Sawers S.J. Relationship between urine flow rate and renal clearance of caffeine in man. J Clin Pharmacol 23 4 (1983) 134-138
12. Trang J.M., Blanchard J., Conrad K.A., and Harrison G.G. Relationship between total body clearance of caffeine and urine flow rate in elderly men. Biopharm Drug Dispos 6 1 (1985) 51-56
13. Gillot I., Gouyon J.B., and Guignard J.P. Renal effects of caffeine in preterm infants. Biol Neonate 58 3 (1990) 133-136
14. Grandjean A.C., Reimers K.J., Bannick K.E., and Haven M.C. The effect of caffeinated, non-caffeinated, caloric and non-caloric beverages on hydration. J Am Coll Nutr 19 5 (2000) 591-600
15. Armstrong L.E., Pumerantz A.C., Roti M.W., et al. Fluid, electrolyte, and renal indices of hydration during 11 days of controlled caffeine consumption. Int J Sport Nutr Exerc Metab 15 3 (2005) 252-265
16. Izzo Jr. J.L., Ghosal A., Kwong T., Freeman R.B., and Jaenike J.R. Age and prior caffeine use alter the cardiovascular and adrenomedullary responses to oral caffeine. Am J Cardiol 52 7 (1983) 769-773
17. Passmore A.P., Kondowe G.B., and Johnston G.D. Renal and cardiovascular effects of caffeine: a dose-response study. Clin Sci (Lond) 72 6 (1987) 749-756
18. Maughan R.J., and Griffin J. Caffeine ingestion and fluid balance: a review. J Hum Nutr Diet 16 6 (2003) 411-420
19. Neuhauser-Berthold M., Beine S., Verwied S.C., and Luhrmann P.M. Coffee consumption and total body water homeostasis as measured by fluid balance and bioelectrical impedance analysis. Ann Nutr Metab 41 1 (1997) 29-36
20. Bellet S., Roman L., DeCastro O., Kim K.E., and Kershbaum A. Effect of coffee ingestion on catecholamine release. Metabolism 18 4 (1969) 288-291
21. Wemple R.D., Lamb D.R., and McKeever K.H. Caffeine vs caffeine-free sports drinks: effects on urine production at rest and during prolonged exercise. Int J Sports Med 18 1 (1997) 40-46
22. Rieg T., Steigele H., Schnermann J., Richter K., Osswald H., and Vallon V. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 313 1 (2005) 403-409
23. Shirley D.G., Walter S.J., and Noormohamed F.H. Natriuretic effect of caffeine: assessment of segmental sodium reabsorption in humans. Clin Sci (Lond) 103 5 (2002) 461-466
24. Nussberger J., Mooser V., Maridor G., Juillerat L., Waeber B., and Brunner H.R. Caffeine-induced diuresis and atrial natriuretic peptides. J Cardiovasc Pharmacol 15 5 (1990) 685-691
25. Lee J., Ha J.H., Kim S., Oh Y., and Kim S.W. Caffeine decreases the expression of Na+/K+-ATPase and the type 3 Na+/H+ exchanger in rat kidney. Clin Exp Pharmacol Physiol 29 7 (2002) 559-563
26. Massey L.K., and Sutton R.A. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol 172 2 (2004) 555-558
27. Bergman E.A., Massey L.K., Wise K.J., and Sherrard D.J. Effects of dietary caffeine on renal handling of minerals in adult women. Life Sci 47 6 (1990) 557-564
28. Zanardo V., Dani C., Trevisanuto D., et al. Methylxanthines increase renal calcium excretion in preterm infants. Biol Neonate 68 3 (1995) 169-174
29. Davies P.M., Fairbanks L.D., Safranow K., Bending M.R., and Simmonds H.A. An unusual patient with kidney stones composed of 1-methyluric acid. Urol Res 34 1 (2006) 58-60
30. McPhee M.D., and Whiting S.J. The effect of adenosine and adenosine analogues on methylxanthine-induced hypercalciuria in the rat. Can J Physiol Pharmacol 67 10 (1989) 1278-1282
31. Massey L.K., and Whiting S.J. Caffeine, urinary calcium, calcium metabolism and bone. J Nutr 123 9 (1993) 1611-1614
32. Luo D., Sun H., Xiao R.P., and Han Q. Caffeine induced Ca2+ release and capacitative Ca2+ entry in human embryonic kidney (HEK293) cells. Eur J Pharmacol 509 2-3 (2005) 109-115
33. Shuster J., Finlayson B., Scheaffer R.L., Sierakowski R., Zoltek J., and Dzegede S. Primary liquid intake and urinary stone disease. J Chronic Dis 38 11 (1985) 907-914
34. Curhan G.C., Willett W.C., Rimm E.B., Spiegelman D., and Stampfer M.J. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 143 3 (1996) 240-247
35. Curhan G.C., Willett W.C., Speizer F.E., and Stampfer M.J. Beverage use and risk for kidney stones in women. Ann Intern Med 128 7 (1998) 534-540
36. Mandel N. Mechanism of stone formation. Semin Nephrol 16 5 (1996) 364-374
37. Baggio B. Genetic and dietary factors in idiopathic calcium nephrolithiasis. What do we have, what do we need?. J Nephrol 12 6 (1999) 371-374
38. Wrenn K.D., and Oschner I. Rhabdomyolysis induced by a caffeine overdose. Ann Emerg Med 18 1 (1989) 94-97
39. Kamijo Y., Soma K., Asari Y., and Ohwada T. Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia. Vet Hum Toxicol 41 6 (1999) 381-383
40. Holstege C.P., Hunter Y., Baer A.B., Savory J., Bruns D.E., and Boyd J.C. Massive caffeine overdose requiring vasopressin infusion and hemodialysis. J Toxicol Clin Toxicol 41 7 (2003) 1003-1007
41. Walsh I., Wasserman G.S., Mestad P., and Lanman R.C. Near-fatal caffeine intoxication treated with peritoneal dialysis. Pediatr Emerg Care 3 4 (1987) 244-249
42. Belibi F.A., Wallace D.P., Yamaguchi T., Christensen M., Reif G., and Grantham J.J. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol 13 11 (2002) 2723-2729
43. Belibi F.A., Reif G., Wallace D.P., et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66 3 (2004) 964-973
44. Tanner G.A., and Tanner J.A. Chronic caffeine consumption exacerbates hypertension in rats with polycystic kidney disease. Am J Kidney Dis 38 5 (2001) 1089-1095
45. Tofovic S.P., Kost Jr. C.K., Jackson E.K., and Bastacky S.I. Long-term caffeine consumption exacerbates renal failure in obese, diabetic, ZSF1 (fa-fa(cp)) rats. Kidney Int 61 4 (2002) 1433-1344
46. Tofovic S.P., Rominski B.R., Bastacky S., Jackso E.K., and Kost Jr. C.K. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats. Ren Fail 22 2 (2000) 159-179
47. Schwabe U., Ukena D., and Lohse M.J. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 330 3 (1985) 212-221
48. Lin S.L., Chiang W.C., Chen Y.M., Lai C.F., Tsai T.J., and Hsieh B.S. The renoprotective potential of pentoxifylline in chronic kidney disease. J Chin Med Assoc 68 3 (2005) 99-105
49. Rodriguez-Moran M., and Guerrero-Romero F. Pentoxifylline is as effective as captopril in the reduction of microalbuminuria in non-hypertensive type 2 diabetic patients-a randomized, equivalent trial. Clin Nephrol 64 2 (2005) 91-97
50. Navarro J.F., Mora C., Muros M., and Garcia J. Additive antiproteinuric effect of pentoxifylline in patients with type 2 diabetes under angiotensin II receptor blockade: a short-term, randomized, controlled trial. J Am Soc Nephrol 16 7 (2005) 2119-2126
51. Nanra R.S., and Kincaid-Smith P. Chronic effect of analgesics on the kidney. Prog Biochem Pharmacol 7 (1972) 285-323
52. Laska E.M., Sunshine A., Mueller F., Elvers W.B., Siegel C., and Rubin A. Caffeine as an analgesic adjuvant. JAMA 251 13 (1984) 1711-1718
53. Cai Q., Dmitrieva N.I., Michea L.F., Rocha G., Ferguson D., and Burg M.B. Toxicity of acetaminophen, salicylic acid, and caffeine for first-passage rat renal inner medullary collecting duct cells. J Pharmacol Exp Ther 306 1 (2003) 35-42
54. Rengelshausen J., Lindenmaier H., Cihlar T., Walter-Sack I., Haefeli W.E., and Weiss J. Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine. Biochem Biophys Res Commun 320 1 (2004) 90-94
55. Sekine T., Miyazaki H., and Endou H. Molecular physiology of renal organic anion transporters. Am J Physiol Renal Physiol 290 2 (2006) F251-F261
56. Zhang W.Y. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Saf 24 15 (2001) 1127-1142
57. Fox J.M., and Siebers U. Caffeine as a promoter of analgesic-associated nephropathy-where is the evidence?. Fundam Clin Pharmacol 17 3 (2003) 377-392
58. Modlinger P.S., and Welch W.J. Adenosine A1 receptor antagonists and the kidney. Curr Opin Nephrol Hypertens 12 5 (2003) 497-502
59. Evans S.M., Pinto Pereira L.M., and Addae J.I. Neuroprotection by caffeine and pentoxifylline during experimental cerebral ischaemia. West Indian Med J 48 1 (1999) 23-25
60. McLaughlin G.E., Kashimawo L.A., Steele B.W., and Kuluz J.W. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats. Pediatr Crit Care Med 4 3 (2003) 358-362
61. McLaughlin G.E., Schober M., Perez M., Ruiz P., Steele B.W., and Abitbol C. Benefit of theophylline administration in tacrolimus-induced nephrotoxicity in rats. Pediatr Nephrol 18 9 (2003) 860-864 Epub 2003 Jun 26
62. McLaughlin G.E., Alva M.D., and Egea M. Adenosine receptor antagonism in acute tacrolimus toxicity. Nephrol Dial Transplant 21 (2006) 1961-1965 Epub 2006 Mar 7
63. Potier M., Aparicio M., and Cambar J. Protective effect of three xanthine derivatives (theophylline, caffeine and pentoxifylline) against the cyclosporin A-induced glomerular contraction in isolated glomeruli and cultured mesangial cells. Nephron 77 4 (1997) 427-434
64. Leblond F.A., Giroux L., Villeneuve J.P., and Pichette V. Decreased in vivo metabolism of drugs in chronic renal failure. Drug Metab Dispos 28 11 (2000) 1317-1320
65. Perazella M.A. Pharmacologic options available to treat symptomatic intradialytic hypotension. Am J Kidney Dis 38 4 Suppl 4 (2001) S26-S36
66. Sulowicz W., and Radziszewski A. Pathogenesis and treatment of dialysis hypotension. Kidney Int Suppl 104 (2006) S36-S39
67. Gigli G.L., Adorati M., Dolso P., et al. Restless legs syndrome in end-stage renal disease. Sleep Med 5 3 (2004) 309-315
68. Lui S.L., Ng F., and Lo W.K. Factors associated with sleep disorders in Chinese patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 22 6 (2002) 677-682
69. Grosso L.M., and Bracken M.B. Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 15 6 (2005) 460-466
70. Denaro C.P., Brown C.R., Wilson M., Jacob P., and Benowitz N.L. Dose dependency of caffeine metabolism. Clin Pharmacol Ther 48 (1990) 277-285